title: Informal caregivers and the intention to hasten AIDS-related death.
abstract: OBJECTIVE
  To determine the extent to which homosexual men dying of the acquired immunodeficiency syndrome (AIDS) receive medication intended to hasten death. To assess the impact on caregivers of administering medications intended to hasten death.
  
  
  METHODS
  In a prospective study of caregiving partners of men with AIDS (n = 140), characteristics of the ill partner, the caregiver, and the relationship were assessed at baseline and 1 month before the ill partner's death. Three months after the death, caregivers were asked if they had increased their partner's narcotic and/or sedative-hypnotic medication dose and if so, what had been the objective of the increase, and their comfort with their medication decisions.
  
  
  RESULTS
  Of 140 ill partners who died of AIDS, 17 (12.1%) received an increase in the use of medications immediately before death intended to hasten death. Diagnoses and care needs of ill partners who received increases in the use of medications to hasten death did not differ from those of ill partners receiving medication for symptoms. Fourteen increases (10%) in use of medications were administered by caregivers. These caregivers did not differ from those administering medication for symptom control in level of distress, caregiving burden, relationship characteristics, or comfort with the medication decision, but they reported more social support and positive meaning in caregiving.
  
  
  CONCLUSIONS
  The decision to hasten death is not a rare event in this group of men. There is no evidence that it is the result of caregiver distress, poor relationship quality, or intolerable caregiving burden; and it does not cause excessive discomfort in the surviving partner. This study, although small, has implications for the policy debate on assisted suicide.
authors.affiliation: Department of Medicine, University of California, San Francisco, USA.
authors.forename: M
authors.initials: M
authors.lastname: Cooke
authors.forename: L
authors.initials: L
authors.lastname: Gourlay
authors.forename: L
authors.initials: L
authors.lastname: Collette
authors.forename: A
authors.initials: A
authors.lastname: Boccellari
authors.forename: M A
authors.initials: MA
authors.lastname: Chesney
authors.forename: S
authors.initials: S
authors.lastname: Folkman
mesh_terms: D000163:Acquired Immunodeficiency Syndrome; D000328:Adult; D000701:Analgesics, Opioid / Q000008:administration & dosage*; D017028:Caregivers / Q000523:psychology; D003643:Death; D003863:Depression; D028601:Euthanasia, Active; D033101:Euthanasia, Active, Voluntary; D033062:Friends; D006167:Guilt; D006699:Home Care Services; D006801:Humans; D006993:Hypnotics and Sedatives / Q000008:administration & dosage*; D033182:Intention; D008297:Male; D011446:Prospective Studies; D015203:Reproducibility of Results; D017236:Suicide, Assisted; D013727:Terminal Care
chemical_list: D000701:Analgesics, Opioid; D006993:Hypnotics and Sedatives